Archive | Evercyte GmbH

Page 1 of 15
Evercyte contributing to reduced animal testing at key events
Evercyte contributing to reduced animal testing at key events Learn More >
Evercyte contributing to inaugural MOVE Symposium
Evercyte contributing to inaugural MOVE Symposium Learn More >
Evercyte promoting telomerized cell advantages at Small New World symposium
Evercyte promoting telomerized cell advantages at Small New World symposium Learn More >
53496Evercyte immortalized cell lines compatible with OOAC organ on chip technology
Evercyte immortalized cell lines compatible with OOAC organ on chip technology Learn More >
53451Evercyte EVs from human bone marrow-derived MSC (EV-BM-MSC/TERT292)
Evercyte EVs from human bone marrow-derived MSC (EV-BM-MSC/TERT292) Learn More >
Evercyte to showcase latest EV cell factories and recombinant antigen recognition at ISEV 2023 Seattle
Evercyte to showcase latest EV cell factories and recombinant antigen recognition at ISEV 2023 Seattle Learn More >
Evercyte brings EV and senescent cell expertise to EU Horizon CHANGE project
Evercyte brings EV and senescent cell expertise to EU Horizon CHANGE project Learn More >
Evercyte showing EV cell factory capabilities  at IGLD Symposium Frankfurt
Evercyte showing EV cell factory capabilities at IGLD Symposium Frankfurt Learn More >
52872Evercyte synoviocyte and chondrocyte bioassays target osteoarthritis
Evercyte synoviocyte and chondrocyte bioassays target osteoarthritis Learn More >
52704Evercyte senolytic and senomorphic drug testing using cell-based assays
Evercyte senolytic and senomorphic drug testing using cell-based assays Learn More >
Evercyte supports study into extended yeast display libraries for CD81 LEL mutants for EV surface customization
Evercyte supports study into extended yeast display libraries for CD81 LEL mutants for EV surface customization Learn More >
52357Evercyte assay-ready replicative senescent cells
Evercyte assay-ready replicative senescent cells Learn More >
Page 1 of 15